Literature DB >> 25830457

Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study.

Giulio Perugi1, Jules Angst, Jean-Michel Azorin, Charles L Bowden, Sergey Mosolov, Joao Reis, Eduard Vieta, Allan H Young.   

Abstract

OBJECTIVE: To estimate the frequency of mixed states in patients diagnosed with major depressive episode (MDE) according to conceptually different definitions and to compare their clinical validity.
METHOD: This multicenter, multinational cross-sectional Bipolar Disorders: Improving Diagnosis, Guidance and Education (BRIDGE)-II-MIX study enrolled 2,811 adult patients experiencing an MDE. Data were collected per protocol on sociodemographic variables, current and past psychiatric symptoms, and clinical variables that are risk factors for bipolar disorder. The frequency of mixed features was determined by applying both DSM-5 criteria and a priori described Research-Based Diagnostic Criteria (RBDC). Clinical variables associated with mixed features were assessed using logistic regression.
RESULTS: Overall, 212 patients (7.5%) fulfilled DSM-5 criteria for MDE with mixed features (DSM-5-MXS), and 818 patients (29.1%) fulfilled diagnostic criteria for a predefined RBDC depressive mixed state (RBDC-MXS). The most frequent manic/hypomanic symptoms were irritable mood (32.6%), emotional/mood lability (29.8%), distractibility (24.4%), psychomotor agitation (16.1%), impulsivity (14.5%), aggression (14.2%), racing thoughts (11.8%), and pressure to keep talking (11.4%). Euphoria (4.6%), grandiosity (3.7%), and hypersexuality (2.6%) were less represented. In multivariate logistic regression analysis, RBDC-MXS was associated with the largest number of variables including diagnosis of bipolar disorder, family history of mania, lifetime suicide attempts, duration of the current episode > 1 month, atypical features, early onset, history of antidepressant-induced mania/hypomania, and lifetime comorbidity with anxiety, alcohol and substance use disorders, attention-deficit/hyperactivity disorder, and borderline personality disorder.
CONCLUSIONS: Depressive mixed state, defined as the presence of 3 or more manic/hypomanic features, was present in around one-third of patients experiencing an MDE. The valid symptom, illness course and family history RBDC criteria we assessed identified 4 times more MDE patients as having mixed features and yielded statistically more robust associations with several illness characteristics of bipolar disorder than did DSM-5 criteria. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25830457     DOI: 10.4088/JCP.14m09092

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  25 in total

Review 1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

2.  Longitudinal course and characteristics of cyclothymic disorder in youth.

Authors:  Anna R Van Meter; Eric A Youngstrom; Boris Birmaher; Mary A Fristad; Sarah M Horwitz; Thomas W Frazier; L Eugene Arnold; Robert L Findling
Journal:  J Affect Disord       Date:  2017-03-14       Impact factor: 4.839

3.  Identification and initial validation of empirically derived bipolar symptom states from a large longitudinal dataset: an application of hidden Markov modeling to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study.

Authors:  James J Prisciandaro; Bryan K Tolliver; Stacia M DeSantis
Journal:  Psychol Med       Date:  2018-08-29       Impact factor: 7.723

Review 4.  Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France.

Authors:  Roger S McIntyre; Allan H Young; Peter M Haddad
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-25

5.  The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5.

Authors:  In Hee Shim; Jonghun Lee; Moon-Doo Kim; Young-Eun Jung; Kyung Joon Min; Young-Joon Kwon; Ji Sun Kim; Kwanghun Lee; Young Sup Woo; Beomwoo Nam; Jeong Seok Seo; Jung Goo Lee; Duk-In Jon; Inki Sohn; Sung-Yong Park; Bo-Hyun Yoon; Won-Myong Bahk
Journal:  Int J Methods Psychiatr Res       Date:  2019-02-20       Impact factor: 4.035

6.  Distinguishing Bipolar Depression from Unipolar Depression in Youth: Preliminary Findings.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; John Merranko; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Mary Kay Gill; Jeffrey Hunt; Shirley Yen; Martin B Keller; David Axelson; Michael Strober; Satish Iyengar; Neal D Ryan; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-28       Impact factor: 2.576

7.  Bipolar spectrum in major depressive disorders.

Authors:  J Angst; K R Merikangas; L Cui; A Van Meter; V Ajdacic-Gross; W Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-21       Impact factor: 5.270

8.  Depression with Mixed Features in Adolescent Psychiatric Patients.

Authors:  Elisabeth A Frazier; Lance P Swenson; Tracy Mullare; Daniel P Dickstein; Jeffrey I Hunt
Journal:  Child Psychiatry Hum Dev       Date:  2017-06

Review 9.  Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder.

Authors:  Andrea Fagiolini; Anna Coluccia; Giuseppe Maina; Rocco N Forgione; Arianna Goracci; Alessandro Cuomo; Allan H Young
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

10.  Comparison of the Emotion Regulation and Temperament Characteristics Between Depressive Patients With and Without Mixed Features.

Authors:  Halil İbrahim Taş; Kürşat Altinbaş
Journal:  Noro Psikiyatr Ars       Date:  2019-09-12       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.